Sanbo Hospital Management Group Ltd
SZSE:301293
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
30.1
57
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Sanbo Hospital Management Group Ltd
Cash & Cash Equivalents
Sanbo Hospital Management Group Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
S
|
Sanbo Hospital Management Group Ltd
SZSE:301293
|
Cash & Cash Equivalents
ÂĄ822.1m
|
CAGR 3-Years
16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
H
|
Hygeia Healthcare Holdings Co Ltd
HKEX:6078
|
Cash & Cash Equivalents
ÂĄ853.8m
|
CAGR 3-Years
30%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
Cash & Cash Equivalents
ÂĄ5.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
26%
|
CAGR 10-Years
24%
|
|
Hengkang Medical Group Co Ltd
SZSE:002219
|
Cash & Cash Equivalents
ÂĄ449.3m
|
CAGR 3-Years
28%
|
CAGR 5-Years
22%
|
CAGR 10-Years
12%
|
||
X
|
XiAn International Medical Investment Co Ltd
SZSE:000516
|
Cash & Cash Equivalents
ÂĄ667.3m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-3%
|
|
H
|
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
|
Cash & Cash Equivalents
ÂĄ3.9B
|
CAGR 3-Years
98%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Sanbo Hospital Management Group Ltd
Glance View
Sanbo Hospital Management Group Ltd. engages in the provision of neurosurgery medical service. The company is headquartered in Beijing, Beijing and currently employs 1,733 full-time employees. The company went IPO on 2023-05-05. The firm is principally engaged in the operation of neurospecialty hospitals. The firm is also engaged in general hospital operations. The firm's diagnostic and treatment programs include neurosurgery, neurointervention, neurology, neuro-oncology chemotherapy, neuro-oncology radiotherapy, neurocritical care and other diagnostic and treatment programs. The other diagnostic and treatment programs include surgery, internal medicine, obstetrics and gynecology, pediatrics, emergency department, imaging department, laboratory department and others. The firm primarily operates its businesses in the domestic market.
See Also
What is Sanbo Hospital Management Group Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
822.1m
CNY
Based on the financial report for Dec 31, 2023, Sanbo Hospital Management Group Ltd's Cash & Cash Equivalents amounts to 822.1m CNY.
What is Sanbo Hospital Management Group Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
16%
Over the last year, the Cash & Cash Equivalents growth was 43%. The average annual Cash & Cash Equivalents growth rates for Sanbo Hospital Management Group Ltd have been 16% over the past three years .